Browsing by Publisher "E-CENTURY PUBLISHING CORP"
Now showing items 1-1 of 1
-
A new FLT3 inhibitor with two cases: the gilteritinib experience
(E-CENTURY PUBLISHING CORP, 2021)Introduction: In acute myeloid leukemia (AML), a heterogeneous group of leukemias, there are various factors to determine prognosis. Among these prognostic factors, cytogenetic results are increasing in importance day by ...